Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
| Author | Haiying Zhang | en |
| Author | Lizhen Chen | en |
| Author | Yongning Xin | en |
| Author | Yuangui Lou | en |
| Author | Yang Liu | en |
| Author | Shiying Xuan | en |
| Issued Date | 2014-10-01 | en |
| Abstract | Context: Our objective was to evaluate the effect of gene polymorphisms of apolipoprotein C3 (APOC3) on the development of non-alcoholic fatty liver disease (NAFLD) in different populations. Evidence Acquisition: We performed a meta-analysis of all relevant studies published in the literature. A total of 115 clinical trials or reports were identified, but only seven trials met our inclusion criteria. A meta-analysis was performed according to the Cochrane Reviewers’ Handbook recommendations. Results: Five hospital-based and two population-based case-control studies were included in the final analysis. The overall frequency of APOC3 gene polymorphisms was 67.5% (1177/1745) in NAFLD and 68.8% (988/1437) in controls. The summary odds ratio for the association of gene polymorphisms of APOC3 and the risk of NAFLD was 1.03 (95% CI: 0.89-1.22),which was not statistically significant (P > 0.05). Conclusions: Our meta-analysis, while not ruling out possible publication bias, showed no association between gene polymorphisms of APOC3 and the risk of NAFLD development in different populations in the world. | en |
| DOI | https://doi.org/10.5812/hepatmon.23100 | en |
| Keyword | Apolipoprotein | en |
| Keyword | Polymorphisms | en |
| Keyword | NAFLD | en |
| Publisher | Brieflands | en |
| Title | Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-Analysis | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 15440-pdf.pdf
- Size:
- 175.76 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF